Better swab, better catch: study aims to sharpen anal cancer screening

NCT ID NCT02816879

First seen Jul 07, 2026 · Last updated Jul 08, 2026 · Updated 1 time

Summary

This study compares different ways to collect anal cell samples and different HPV tests to see which combination best predicts high-grade anal dysplasia, a pre-cancerous condition. Researchers are enrolling men who have sex with men, including those with and without HIV. The goal is to make screening more accurate so that those at highest risk can be identified and treated earlier.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this could lead to simpler, more accurate screening to catch pre-cancerous changes early in men at higher risk.
What could go wrong
This is an observational comparison of existing tests, not a treatment trial. Results may not change current screening guidelines.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANAL CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Desert AIDS Project

    Palm Springs, California, 92262, United States

  • Los Angeles Gay and Lesbian Center

    Los Angeles, California, 90028, United States

  • UCLA / Jonsson Comprehensive Cancer Center

    Los Angeles, California, 90095, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.